Faron Pharmaceuticals Oy (AIM:FARN)
35.00
-0.50 (-1.41%)
Sep 25, 2026, 9:41 AM GMT
Faron Pharmaceuticals Oy Employees
Faron Pharmaceuticals Oy had 36 employees as of June 30, 2026. The number of employees increased by 3 or 9.09% since the number was reported on December 31, 2025.
Employees
36
Change
3
Growth
9.09%
Revenue / Employee
n/a
Profits / Employee
-390.93K GBP
Market Cap
73.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 36 | 3 | 9.09% |
| Dec 31, 2025 | 33 | 8 | 32.00% |
| Dec 31, 2024 | 25 | -9 | -26.47% |
| Dec 31, 2023 | 34 | -6 | -15.00% |
| Dec 31, 2022 | 40 | 3 | 8.11% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| 4basebio | 140 |
| PureTech Health | 90 |
| IXICO | 79 |
| Scancell Holdings | 60 |
| Arecor Therapeutics | 33 |
| Hemogenyx Pharmaceuticals | 16 |
| Poolbeg Pharma | 15 |
| Bioventix | 12 |
Faron Pharmaceuticals Oy News
- 4 weeks ago - Faron Pharmaceuticals Oy Earnings Call Transcript: H1 2026 - Transcripts
- 4 weeks ago - Faron Pharmaceuticals Oy Quarterly report: H1 2026 - Filings
- 4 weeks ago - Faron Pharmaceuticals Oy Slides: H1 2026 - Filings
- 6 weeks ago - Faron Pharmaceuticals share price targets 762% on bexmarilimab trial momentum - ABC Money
- 3 months ago - Faron Pharmaceuticals Oy Transcript: Status update - Transcripts
- 3 months ago - Faron Pharmaceuticals Oy Press release: Status update - Filings
- 6 months ago - Faron Pharmaceuticals Oy Transcript: Investor update - Transcripts
- 6 months ago - Faron Pharmaceuticals Oy Slides: Investor update - Filings